| Anna R. Franklin, M.D. |
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Pediatrics Patient Care, Division of Pediatrics, Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center, Leukemia/Lymphoma Section, Houston, TX
Education & Training
Degree-Granting Education | |
| 1997 | The University of Texas Medical School, Houston, TX, MD, Medicine |
| 1992 | The University of Saint Thomas, Houston, TX, BS, Biology |
Postgraduate Training | |
| 7/2003-6/2004 | Chief Fellow, Pediatric Hematology/Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, Paul Meyers, MD |
| 7/2001-6/2004 | Fellowship, Pediatric Hematology/Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, Paul Meyers, MD |
| 7/1997-6/2001 | Residency, Internal Medicine & Pediatrics, University of Texas Medical School, Houston, TX, Mark Farnie, MD |
Board Certifications
| 2004 | Pediatric Hematology Oncology |
| 2002 | Pediatrics |
| 2001 | Internal Medicine |
Experience/Service
Academic Appointments
Instructor, Division of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 9/2004-9/2006
Selected Publications
Peer-Reviewed Original Research Articles | |
| 1. | Chinen J, Anmuth D, Franklin ARK, Shearer WT. Long term follow-up of patients with primary immunodeficiency. Journal of Allergy and Clinical Immunology 122(5):1036-7, 11/2008. |
| 2. | Borsotti C, Franklin AR, Lu SX, Kim TD, Smith OM, Suh D, King CG, Chow A, Liu C, Alpdogan O, van den Brink MRM. Absence of donor T-cell-derived soluble TNF decreases graft-versus- host disease without impairing graft-versus-tumor activity. Blood 11(2). e-Pub 3/2007. |
| 3. | Giles FJ, Shi GG, Cortes JE, Thomas D, Keating AR, Kantarjian HM, Keating MJ, OBrien SM. Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia. Cancer Chemotherapy & Pharmacology 52(3):223-228, 2003. |
| 4. | Giles FJ, Keating AR, Kantarjian HM, Kurzrock R, Talpaz M. Pilot study of recombinant interleukin 4 therapy of myelofibrosis. Journal of Interferon and Cytokine Research 19(11):1253-1255, 1999. |
Last updated: 9/23/2009
- Global Navigation
- About Us
- Locations
- Events
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient & Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children’s Cancer Hospital
- Services & Amenities
- Physician Directory
- Education and Research
- Departments, Programs & Labs
- PeopleFinder
- Research at M.D Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alerts
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
© 2009 The University of Texas M. D. Anderson Cancer Center

